Form 4 for EW Edwards Lifesciences
Accepted 2024-05-09 00:00:00 ET · period of report 2024-05-07 · accession 0001225208-24-005884 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-09 | 2024-05-07 | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | A - Grant | $0.00 | +2,445 | 17.5K | +16% | $0 |
| D | 2024-05-09 | 2024-05-07 | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | F - Tax | $85.09 | -178 | 17.3K | -1% | -$15.1K |
| D | 2024-05-09 | 2024-05-07 | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | A - Grant | $0.00 | +4,820 | 4,820 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-07 | A | A | 2,445 | $0.00 | 17,488.20 | D | — | — | (F1) These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. |
| 2 | Common | Common Stock | 2024-05-07 | F | D | 178 | $85.09 | 17,310.20 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2024-05-07 | A | A | 4,820 | $0.00 | 4,820 | D | $85.84 · 2025-05-07 to 2031-05-06 | 4,820 Common Stock | (F2) These options were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments. |